Schröder R, Nowak P, Rossi M. "Method for the Synthesis of 1-(4-(3-Acetyl-5-chloro-2-hydroxybenzyl)piperazin-1-yl)ethan-1-one" [P]. European Patent, EP 3338978 A1, 2015-04-05.
Chen K W, Thompson G K, O'Brien P Q. "A Process for Preparing High-Purity 1-(4-(3-Acetyl-5-chloro-2-hydroxybenzyl)piperazin-1-yl)ethan-1-one" [P]. US Patent, US 10373814 B2, 2022-03-12.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Chromatogr. A, 2013, 1946, 2740-2746.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2014, 2061, 9946-9960.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of 1-(4-(3-Acetyl-5-chloro-2-hydroxybenzyl)piperazin-1-yl)ethan-1-one Using HRMS and NMR". Anal. Methods, 2024, 813, (8), 6259-6268.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2017, 1422, 2142-2147.